Search results for "SCALE"

showing 10 items of 5180 documents

Type D personality as a cardiovascular risk marker in the general population: results from the Gutenberg health study.

2011

<i>Background:</i> Type D personality is considered as an independent risk factor for morbidity and mortality in cardiovascular patients and a vulnerability factor for distress in the general population. Because representative community studies are rare, we sought to determine the prevalence of type D personality and its relationship with demographic characteristics, different features of mental disorders, cardiovascular risk factors, health behavior, endothelial function and cardiovascular biomarkers in the general population. <i>Methods:</i> The prevalence of type D personality and its correlates were analyzed cross-sectionally in a population-based sample of 5,000…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectPopulationHealth BehaviorCoronary DiseaseAnxietyPersonality AssessmentPersonality DisordersGermanyInterview PsychologicalmedicinePersonalityHumansEndotheliumRisk factoreducationPsychiatryLife StyleApplied PsychologyDepression (differential diagnoses)media_commonAgedDyslipidemiasPsychiatric Status Rating Scaleseducation.field_of_studyDepressionType D personalityGeneral MedicineMiddle AgedPatient Acceptance of Health CarePsychiatry and Mental healthClinical PsychologyDistressAnxietyFemalemedicine.symptomPersonality Assessment InventoryPsychologyBiomarkersStress PsychologicalClinical psychologyPersonalityPsychotherapy and psychosomatics
researchProduct

Risperidone in the Treatment of Disorders with a combined Psychotic and Depressive Syndrome - A Functional Approach

1992

In vitro receptor-binding profiles and in vivo pharmacological studies have shown risperidone to be a potent mixed serotonin-S2 dopamine-D2-like receptor antagonist. While anti-D2 activity may relate to the antipsychotic potency of neuroleptic drugs, an antidepressive efficacy of substances with anti-S2 activity has been suggested. In an open pilot-study, ten patients with schizodepressive disorders or a DSM-III-R diagnosis of psychotic major depressive episodes were treated with risperidone (2-10 mg/d) for six weeks. Weekly psychopathological evaluation was performed, including BPRS, SANS, SAPS, VAS scales, and AIMS and UKU for the assessment of side-effects. Generally, the psychotic syndr…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentPiperidinesInternal medicineHumansMedicinePotencyPharmacology (medical)AntipsychoticDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderRisperidonebusiness.industryDopamine antagonistIsoxazolesSyndromeGeneral MedicineMiddle AgedRisperidoneReceptor antagonistBiperidenPsychiatry and Mental healthPsychotic DisordersAnesthesiaFemalebusinessAntipsychotic AgentsPsychopathologymedicine.drugPharmacopsychiatry
researchProduct

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.

2011

Abstract Background To examine the influencing factors and predictors of early improvement in schizophrenia patients. Methods 370 patients suffering from a schizophrenia spectrum disorder were examined within a naturalistic multicenter study. Early improvement was defined as a ≥30% PANSS total score reduction within the first two treatment weeks, response as a ≥50% improvement of the PANSS total score from admission to discharge and remission according to the consensus remission criteria. Baseline and course-related variables such as positive, negative and depressive symptoms, side effects, functioning and subjective well-being were examined regarding their explanatory value for early impro…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentMedizinAntipsychotic treatment03 medical and health sciencesYoung Adult0302 clinical medicineRemission criteriaPredictive Value of TestsInternal medicinemedicineHumansPsychiatryAntipsychoticBiological PsychiatryDepressive symptomsRetrospective StudiesPsychiatric Status Rating Scalesbusiness.industryMiddle Agedmedicine.disease030227 psychiatry3. Good healthDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthTreatment OutcomeMulticenter studyROC CurveSchizophreniaSchizophreniaFemalebusiness030217 neurology & neurosurgerySchizophrenia spectrumAntipsychotic AgentsFollow-Up StudiesJournal of psychiatric research
researchProduct

Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives

2010

"Cognitive impairment has been recognized since the earliest descriptions of schizophrenia as a core feature of the illness and different programmes have been developed to remediate these deficits. In all likelihood it is important for compliance and adherence to treatment that not only the patients but also their relatives be aware of the patients; cognitive deficits. Sixty-two patients with a diagnosis of schizophrenia and, for each one of them, one family member and an informant from the medical staff, were recruited and administered the Schizophrenia Cognition Rating Scale (SCoRS) ratings. Patients were tested for cognitive deficits with a neuropsychological battery and their performanc…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentNeuropsychological TestsExecutive FunctionmedicineHumansFamilyCognitive skillFirst-degree relativesPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesRehabilitationCognitionAwarenessmedicine.diseaseExecutive functionsPsychiatry and Mental healthCognitive remediation therapySchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersDiagnosis of schizophreniaClinical psychology
researchProduct

The DSM-IV nosology of chronic pain: a comparison of pain disorder and multiple somatization syndrome.

2000

This study evaluates the classification of pain from the perspective of the DSM-IV system. Of 60 in-patients with long-standing and disabling pain syndromes, 29 with pain disorder (PD) and 31 with pain as part of a multiple somatization syndrome (MSS) were compared before and after a structured cognitive-behavioral treatment. It was hypothesized that MSS patients show more psychological distress, are more severely disabled, and respond less to the treatment. Both groups were similar with respect to sociodemographic status, history of pain symptomatology and comorbidity with DSM-IV mental disorders. The results show that MSS patients had higher levels of affective and sensoric pain sensation…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPainAdaptation PsychologicalmedicineHumansPain ManagementSomatization disorderPsychiatrySomatoform DisordersAgedPain MeasurementPsychiatric Status Rating ScalesPain disorderCognitive Behavioral TherapyMental DisordersChronic painMiddle Agedmedicine.diseaseComorbidityCognitive behavioral therapyAnesthesiology and Pain MedicineCross-Sectional StudiesTreatment OutcomeChronic DiseaseAnxietyPain catastrophizingFemalemedicine.symptomPsychologySomatizationAttitude to HealthClinical psychologyEuropean journal of pain (London, England)
researchProduct

Life goals after brain injury in the light of the dual process approach: empirical evidence and implications for neuropsychological rehabilitation.

2011

Sequelae of acquired brain injury endanger the realisation of important life-goals. Discrepancies arise between the importance attached to a goal and the success in realising it. This study investigates goal discrepancies and their influence on patients' subjective well-being (SWB) in different rehabilitation stages. Life-goals, SWB and daily functioning were assessed in 130 neurological inpatients and 42 outpatients by self-report questionnaires. Both patient groups reported greater discrepancies between importance and success of life-goals than a normative sample of healthy controls. In multiple regression modelling, goal discrepancy predicted SWB in the inpatient sample even when control…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPoison controlPersonal SatisfactionSeverity of Illness IndexOccupational safety and healthArts and Humanities (miscellaneous)Injury preventionActivities of Daily LivingmedicineHumansSubjective well-beingPsychiatryAcquired brain injuryApplied PsychologyPsychiatric Status Rating ScalesRehabilitationRehabilitationNeuropsychologyHuman factors and ergonomicsMiddle Agedmedicine.diseaseNeuropsychology and Physiological PsychologyBrain InjuriesCase-Control StudiesFemaleSelf ReportPsychologyGoalsClinical psychologyNeuropsychological rehabilitation
researchProduct

Outcomes of uvulopalatopharyngoplasty with harmonic scalpel after failure of continuous positive airway pressure in sleep apnea syndrome.

2012

Our data highlight that uvulopalatopharyngoplasty (UPPP) with harmonic scalpel (HS) is a reliable treatment in selected patients affected by obstructive sleep apnea (OSA) and users of continuous positive airway pressure (CPAP).The aim of this paper was to verify the efficacy and applicability of UPPP with HS in the treatment of patients affected by OSA and users of CPAP.A total of 21 patients with a retropalatal obstruction and users of CPAP underwent UPPP with HS and were evaluated (before and 6 months after surgery) using the apnea/hypopnea index (AHI); oxygen desaturation index ≥4% (ODI(4)); Epworth Sleepiness Scale (ESS); snoring level (SL); subjective assessment of the postoperative pa…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPostoperative painstomatognathic systemUltrasonic Surgical ProceduresmedicineHumansContinuous positive airway pressureTreatment FailureOxygen desaturation indexAgedSleep Apnea ObstructiveEpworth Sleepiness Scale; Obstructive sleep apnea; Oxygen desaturation index; Postoperative painContinuous Positive Airway Pressurebusiness.industryEpworth Sleepiness ScaleUvulopalatopharyngoplastySleep apneaApneaGeneral MedicineMiddle Agedmedicine.diseaseEpworth Sleepiness ScaleObstructive sleep apneaapnea/hypopnea indexnervous system diseasesrespiratory tract diseasesSurgeryObstructive sleep apneaOtorhinolaryngologyApnea–hypopnea indexUvulaAnesthesiaObstructive sleep apnea; apnea/hypopnea index; oxygen desaturation index; Epworth Sleepiness Scale; postoperative painPharynxFemalemedicine.symptomPalate SoftbusinessHypopneaActa oto-laryngologica
researchProduct

Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis

2020

Abstract An ever-expanding number of disease-modifying drugs for multiple sclerosis have become available in recent years, after demonstrating efficacy in clinical trials. In the real-world setting, however, disease-modifying drugs are prescribed in patient populations that differ from those included in pivotal studies, where extreme age patients are usually excluded or under-represented. In this multicentre, observational, retrospective Italian cohort study, we evaluated treatment exposure in three cohorts of patients with relapsing-remitting multiple sclerosis defined by age at onset: paediatric-onset (≤18 years), adult-onset (18–49 years) and late-onset multiple sclerosis (≥50 years). We…

AdultMalemedicine.medical_specialtyneuroinflammationCohort Studies03 medical and health sciences0302 clinical medicineMultiple Sclerosis Relapsing-RemittingInternal medicinemedicineHumansDisabled Persons030212 general & internal medicineProspective StudiesRisk factorclinical trials; clinically isolated syndrome; demyelination; multiple sclerosis epidemiology; neuroinflammationRetrospective Studiesclinical trialsClinically isolated syndromeExpanded Disability Status ScaleProportional hazards modelbusiness.industryHazard ratioMiddle AgedItalyAntirheumatic Agentsclinically isolated syndromeCohortDisease Progressionmultiple sclerosis epidemiologySettore MED/26 - NeurologiaFemaleNeurology (clinical)demyelinationAge of onsetbusiness030217 neurology & neurosurgeryCohort studyFollow-Up Studies
researchProduct

Alfa-lipoic acid and superoxide dismutase in the management of chronic neck pain: a prospective randomized study

2014

Background and Objective Since oxidative stress plays a pathogenetic role in chronic neck pain (CNP), we investigated whether a combination of α-lipoic acid (ALA) and superoxide dismutase (SOD) might improve pain control and the efficacy of physiotherapy (“multimodal therapy”) in patients with CNP. Setting This study was conducted in the Rehabilitation Unit of the Department of Surgical and Oncological Sciences at the University Policlinic in Palermo, Italy. Design and Patients This was a prospective, randomized, open study in outpatients. Intervention Patients randomly received either physiotherapy alone (group 2; n = 45) or a combination of ALA 600 mg and SOD 140 IU daily in addition to p…

AdultMalemedicine.medical_specialtyperipheral neuropathyVisual Analog Scalemedicine.disease_causeBioinformaticsGastroenterologyalfa-lipoic acidSuperoxide dismutasechemistry.chemical_compoundInternal medicinemedicineHumansOriginal Research ArticleProspective StudiesProspective cohort studyPhysical Therapy ModalitiesAgedAged 80 and overPharmacologyNeck painNeck PainThioctic Acidbiologybusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaChronic painMultimodal therapyMiddle Agedmedicine.diseaseCombined Modality Therapysuperoxide dismutaseLipoic acidchemistrychronic neck painNeuropathic painbiology.proteinantioxidant supplementationFemaleChronic Painmedicine.symptombusinessOxidative stress
researchProduct

Photobiomodulation using high- or low-level laser irradiations in patients with lumbar disc degenerative changes: disappointing outcomes and remarks

2018

Jakub Taradaj,1,2 Katarzyna Rajfur,3 Barbara Shay,2 Joanna Rajfur,3 Kuba Ptaszkowski,4 Karolina Walewicz,3 Robert Dymarek,5 Mirosław Sopel,5 Joanna Rosińczuk5 1Department of Physiotherapy Basics, Academy of Physical Education, Katowice, Poland; 2College of Rehabilitation Sciences, University of Manitoba, Winnipeg, MB, Canada; 3Public Higher Medical Professional School, Opole, Poland; 4Department of Clinical Biomechanics and Physiotherapy in Motor System Disorders, Wroclaw Medical University, Wroclaw, Poland; 5Department of Nervous System Diseases, Wroclaw Medical University, Wroclaw, Poland Background: Laser therapy seems to be a beneficial physical agent for chronic low back pain (LBP), …

AdultMalemedicine.medical_specialtyphotobiomodulation therapyVisual analogue scalemedicine.medical_treatmentPlacebo030207 dermatology & venereal diseases03 medical and health sciencesLumbar disc0302 clinical medicinelaser therapymedicineHumansIn patientProspective StudiesLow-Level Light TherapyOriginal ResearchPain MeasurementRehabilitationLumbar Vertebraebusiness.industryGeneral MedicineMiddle AgedLow back painOswestry Disability IndexClinical trialTreatment OutcomeClinical Interventions in AgingPhysical therapyFemaleGeriatrics and Gerontologymedicine.symptombusinessLow Back Pain030217 neurology & neurosurgerylumbar disc degenerative changesClinical Interventions in Aging
researchProduct